<?xml version="1.0" encoding="UTF-8"?>
<p>HK catalyzes the first step in glucose metabolism converting glucose to glucose-6-phosphate [
 <xref rid="B29" ref-type="bibr">29</xref>]. HK2 status is clinically linked to recurrence and poor prognosis in BC [
 <xref rid="B31" ref-type="bibr">31</xref>]. This enzyme plays a pivotal role in tumor glycolysis. Inhibition of HK2 has been shown to inhibit the proliferation of cancer cells by shifting the glycolytic pathway with reduced lactate formation [
 <xref rid="B32" ref-type="bibr">32</xref>]. Here, the levels of HK2 were significantly decreased in MDA-MB-231 cells after propolis treatment, as determined by multiple measurement methods.
</p>
